CANDICE SANDERS: Open Payments
NPI 1962954321 · CYPRESS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$965 in 43 payments from 9 companies in 2025. Trend: 2023 $18 · 2024 $1,045 · 2025 $965
Food & beverage: $965
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $440 |
| Madrigal Pharmaceuticals | 6 | $209 |
| Ipsen Biopharmaceuticals, Inc | 1 | $139 |
| QOL Medical, LLC | 3 | $77 |
| Lilly USA, LLC | 1 | $31 |
| Phathom Pharmaceuticals, Inc. | 2 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| Aimmune Therapeutics, Inc. | 1 | $14 |
| Ardelyx, Inc. | 1 | $14 |
Products named: LINZESS, REZDIFFRA, CREON, IQIRVO, Sucraid, OMVOH, VOQUEZNA, VIBERZI.
Industry payments across TX — which companies pay providers there.
